Monogram Biosciences, Inc.

Abstract

For Monogram Biosciences, fighting HIV is personal. The diagnostics company operates in the growing field of personalized medicine, creating laboratory tests that help doctors tailor treatments for infectious disease and cancer based on each individual patient's genetic traits. Its PhenoSense, GenSeq, and Trofile tests determine patients' drug resistance to various classes of HIV drugs. Monogram Biosciences also markets the HERmark assay to test for protein markers in breast cancer patients. Monogram markets its products to doctors and reference laboratories (for patient treatment) and to drug researchers (for clinical trials). The company is owned by LabCorp.